Doxycycline: A sclerosant agent to treat a case of recurrent thyroglossal duct cyst.
Thyroglossal duct cyst (TGDC) is one of the most common congenital anterior midline neck masses in children. Sistrunk operation is considered as the cornerstone in TGDC removal. Nevertheless, 5% to 7 % of patients have been reported to show a recurrence even after adequate resection. This necessitates at times multiple resections with potential complications. One interesting emerging technique is sclerotherapy of TGDC remnants post resection. We present here a case of a child who had a successfully treated recurrent TGDC using sclerotherapy with doxycycline.
Department of Otolaryngology-Head and Neck Surgery, The Montreal Children's Hospital, McGill University, Montreal, QC, Canada.
Farid F
FF
Ibrahim
Department of Otolaryngology-Head and Neck Surgery, The Montreal Children's Hospital, McGill University, Montreal, QC, Canada. Electronic address: sam.daniel@mcgill.ca.
Sam J
SJ
Daniel
D003131:Combined Modality Therapy; D004318:Doxycycline / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007223:Infant; D012008:Recurrence; D012597:Sclerosing Solutions / Q000627:therapeutic use*; D015911:Sclerotherapy / Q000379:methods*; D013955:Thyroglossal Cyst / Q000601:surgery / Q000628:therapy*
D012597:Sclerosing Solutions; D004318:Doxycycline
Cyst; Doxycycline; Recurrent; Sclerotherapy; Sistrunk; Thyroglossal